Assessing policies for the implementation of new technological interventions to combat COVID-19

ABSTRACT

The second panelist will discuss policy and politics, incl. the role expert bodies and instruments of the European Union, assessing the role of the European Commission and the exchange frameworks with Member-States. In the context of elaboration on how optimal strategies for assessing the impact of new health technology and for evidence-informed policymaking, the role the European Group on Ethics in Science and New Technologies (EGE) will be discussed in more detail, as the independent expert group and multi-disciplinary body appointed by the President of the European Commission to advises on all policies where ethical, societal and fundamental rights issues intersect with the development of science and new technologies. Furthermore, broad long-term implications for globalisation and the relation of the EU to third countries will be examined, as will the significance of such measures for the European Union's Global Health Agenda, and the implications for future decision-making and policies in developing countries too.